A new-drug roundup.
Davis
W M
WM
Department of Pharmacology, University of Mississippi, School of Pharmacy, USA.
Waters
I W
IW
D000085:Acetates / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D000069287:Capecitabine; D003521:Cyclopropanes; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004358:Drug Therapy / Q000451:nursing*; D064420:Drug-Related Side Effects and Adverse Reactions; D000068800:Etanercept; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D011804:Quinolines / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012293:Rifampin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013440:Sulfides; D013450:Sulfones; D013873:Thionucleotides / Q000627:therapeutic use
D000085:Acetates; D018927:Anti-Asthmatic Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D000998:Antiviral Agents; D003521:Cyclopropanes; D007074:Immunoglobulin G; D007555:Isoxazoles; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D011804:Quinolines; D018124:Receptors, Tumor Necrosis Factor; D013440:Sulfides; D013450:Sulfones; D013873:Thionucleotides; D003841:Deoxycytidine; D000069287:Capecitabine; D000068677:Sildenafil Citrate; D000077339:Leflunomide; C093875:montelukast; D000068800:Etanercept; C091346:fomivirsen; D005472:Fluorouracil; D012293:Rifampin; C018421:rifapentine